These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 33823324)

  • 1. Immunoengineering the next generation of arthritis therapies.
    Klimak M; Nims RJ; Pferdehirt L; Collins KH; Harasymowicz NS; Oswald SJ; Setton LA; Guilak F
    Acta Biomater; 2021 Oct; 133():74-86. PubMed ID: 33823324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomaterial-based immunotherapeutic strategies for rheumatoid arthritis.
    Tu AB; Lewis JS
    Drug Deliv Transl Res; 2021 Dec; 11(6):2371-2393. PubMed ID: 34414564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomaterial Strategies for Immunomodulation.
    Hotaling NA; Tang L; Irvine DJ; Babensee JE
    Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoengineering has arrived.
    Green JJ
    J Biomed Mater Res A; 2021 Apr; 109(4):397-403. PubMed ID: 32588490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
    Xie YQ; Wei L; Tang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes.
    Derakhshankhah H; Sajadimajd S; Jahanshahi F; Samsonchi Z; Karimi H; Hajizadeh-Saffar E; Jafari S; Razmi M; Malvajerd SS; Bahrami G; Razavi M; Izadi Z
    Tissue Eng Part B Rev; 2022 Oct; 28(5):1053-1066. PubMed ID: 34696626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical Immunoengineering of T cells for Therapeutic Applications.
    Lei K; Kurum A; Tang L
    Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis.
    Hwang JJ; Rim YA; Nam Y; Ju JH
    Front Immunol; 2021; 12():631291. PubMed ID: 33763076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential.
    Li ZA; Sant S; Cho SK; Goodman SB; Bunnell BA; Tuan RS; Gold MS; Lin H
    Trends Biotechnol; 2023 Apr; 41(4):511-527. PubMed ID: 35995600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomaterials as Local Niches for Immunomodulation.
    Adu-Berchie K; Mooney DJ
    Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic Cells as Targets for Biomaterial-Based Immunomodulation.
    Eslami-Kaliji F; Sarafbidabad M; Rajadas J; Mohammadi MR
    ACS Biomater Sci Eng; 2020 May; 6(5):2726-2739. PubMed ID: 33463292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for reducing inflammation and promoting bone repair in arthritis.
    Neto MF; Yokota H; Figueiredo ML
    Front Biosci (Landmark Ed); 2018 Jan; 23(2):318-347. PubMed ID: 28930550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 and articular cartilage: experimental therapeutical approaches in cartilage disorders.
    Schulze-Tanzil G; Zreiqat H; Sabat R; Kohl B; Halder A; Müller RD; John T
    Curr Gene Ther; 2009 Aug; 9(4):306-15. PubMed ID: 19534651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial drug delivery approaches for immunomodulation.
    Stewart JM; Keselowsky BG
    Adv Drug Deliv Rev; 2017 May; 114():161-174. PubMed ID: 28532690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases.
    Zarubova J; Zhang X; Hoffman T; Hasani-Sadrabadi MM; Li S
    Matter; 2021 May; 4(5):1528-1554. PubMed ID: 33723531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-Modulating Hydrogels for Osteoarthritis Cartilage Tissue Engineering.
    Koh RH; Jin Y; Kim J; Hwang NS
    Cells; 2020 Feb; 9(2):. PubMed ID: 32059502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomaterial Integration in the Joint: Pathological Considerations, Immunomodulation, and the Extracellular Matrix.
    von Mentzer U; Corciulo C; Stubelius A
    Macromol Biosci; 2022 Jul; 22(7):e2200037. PubMed ID: 35420256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.